Iza-Bren Significantly Improves Overall and Progression-Free Survival in Triple-Negative Breast Cancer and Esophageal Cancer SystImmune, Inc., a clinical-stage biotechnology company focused on developing innovative cancer therapies, and Bristol Myers Squibb have announced encouraging results from two pivotal Phase 3 clinical…
Novel Blood Test Reveals Key Tumor Microenvironment Signals Predictive of Immunotherapy Outcomes in Sarcoma Aqtual, Inc., a precision medicine company focused on developing advanced cell-free DNA (cfDNA) diagnostics for oncology and chronic diseases, has announced new research findings demonstrating the…
Lysoway Therapeutics Secures Additional MJFF Funding to Advance TMEM175 Agonist Program for Parkinson’s Disease Lysoway Therapeutics, a biopharmaceutical company focused on developing small-molecule therapies that target lysosomal ion channels, has announced that it has received an additional research grant from…
Meiji Seika Pharma Invests in Global Health Security Fund to Advance Pandemic Preparedness and Infectious Disease Innovation Meiji Seika Pharma Co., Ltd., one of Japan’s leading pharmaceutical companies with a long-standing focus on infectious disease research and development, has announced…
Pfizer and Innovent Biologics Forge Major Global Oncology Partnership to Advance Next-Generation Cancer Medicines Pfizer Inc. and Innovent Biologics have announced a landmark strategic global licensing and collaboration agreement aimed at accelerating the discovery, development, and commercialization of a new…
BeOne Medicines Reports Phase 3 HERIZON-GEA Results Published in NEJM and Featured at ASCO 2026 BeOne Medicines has announced the publication and upcoming presentation of significant new clinical data from the HERIZON-GEA-01 trial evaluating ZIIHERA in combination with chemotherapy, with…
Cosm Medical Enters Licensing and Collaboration Agreement to Advance Personalized Gynethotics™ Devices for Post-Surgical Pelvic Recovery Cosm Medical Corp. has announced a new licensing and collaboration agreement with Duke Health and Mayo Clinic aimed at developing and commercializing a new…
New Research on Headache Treatments, Biomarkers, and the Gut-Brain Connection to Be Featured at the American Headache Society® 68th Annual Scientific Meeting American Headache Society is preparing to host its 68th Annual Scientific Meeting from June 4–7 at the Orlando…
Arrowhead Pharmaceuticals Unveils Encouraging Clinical Cardiometabolic Findings at the 94th European Atherosclerosis Society Congress Arrowhead Pharmaceuticals has presented new clinical findings supporting the broader use of plozasiran, its investigational small interfering RNA therapy targeting apolipoprotein C-III (APOC3), during two oral…
Aphios Corporation Receives Patent Allowance for Innovative Bryoid Composition Platform Aimed at Alzheimer’s, Multiple Sclerosis, HIV Reservoirs, and Oncology Applications Aphios Corporation has announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for…
BreezeBio Establishes Scientific Advisory Board to Advance Precision Genetic Medicine Pipeline BreezeBio, formerly known as GenEdit, has announced the formation of its inaugural Scientific Advisory Board (SAB), marking a significant step in the company’s ongoing expansion as it advances a…
TFG-001 Shows Enhanced Neural Function and Reinnervation Potential in Parkinson’s Disease Cell Therapy Research TreeFrog Therapeutics has announced new preclinical findings for its investigational Parkinson’s disease cell therapy candidate, TFG-001, ahead of presentation at the 7th World Parkinson Congress. The…